PPARG and non-small cell lung carcinoma: Based on an intervention performed by Haynes et al., inhaled celecoxib resulted in in vitro cytotoxic and apoptotic responses against human NSCLC, demonstrated by the increase in PPAR-γ and p53 expression [41].